ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281 | -34.7% | 14,013 | -8.2% | 0.00% | -33.3% |
| Q2 2023 | $430 | +77.7% | 15,258 | +8.5% | 0.00% | +50.0% |
| Q1 2023 | $242 | -12.3% | 14,065 | +2.5% | 0.00% | 0.0% |
| Q4 2022 | $276 | -99.9% | 13,717 | -7.9% | 0.00% | 0.0% |
| Q3 2022 | $323,000 | +53.8% | 14,894 | +99.7% | 0.00% | +100.0% |
| Q2 2022 | $210,000 | -2.3% | 7,460 | +59.8% | 0.00% | 0.0% |
| Q1 2022 | $215,000 | -40.8% | 4,669 | +8.0% | 0.00% | -50.0% |
| Q4 2021 | $363,000 | +67.3% | 4,323 | +32.5% | 0.00% | +100.0% |
| Q3 2021 | $217,000 | – | 3,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |